arimoclomol citrate
arimoclomol citrate is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including MIPLYFFA. Available dosage form: capsule.
Drug Details
- Generic Name
- arimoclomol citrate
- Brand Names
- MIPLYFFA
- Application Number
- NDA214927
- Sponsor
- Patheon France S.A.S.
- NDC Codes
- 8
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- ARIMOCLOMOL CITRATE
Indications and Usage
1 INDICATIONS AND USAGE MIPLYFFA is indicated for use in combination with miglustat for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adult and pediatric patients 2 years of age and older. MIPLYFFA is indicated for use in combination with miglustat for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adult and pediatric patients 2 years of age and older. ( 1 )